Literature DB >> 2108811

Halothane inhibits hypoxic pulmonary vasoconstriction in the presence of cyclooxygenase blockade.

D Johnson1, I Mayers, T Hurst.   

Abstract

Using an isolated lung the effects of halothane on hypoxic pulmonary vasoconstriction (HPV) were studied in the presence of cyclooxygenase blockade. The pulmonary vasculature can be divided into arterial, middle and venous segment resistances. Analysis of the vascular pressure-flow relationship further separates resistance into a flow dependent resistance (1/slope) and a zero-flow pressure intercept (PCRIT). We ventilated six lobes with control (35 per cent O2) and hypoxic (three per cent O2) gas mixtures with the addition of either 0, 0.5, 1.0, or 2.0 per cent halothane. We found that after addition of indomethacin (5 mg.kg-1), ventilation with three per cent O2 increased total resistance by 87 per cent over baseline with the increase primarily in the middle vascular segment. During normoxic ventilation PCRIT was 7.9 cm H2O and this increased significantly with hypoxia to 11.5 cm H2O). Only 2.0 per cent halothane blocked the increases in middle segment resistance and in PCRIT. We conclude that following cyclooxygenase blockade, halothane inhibits HPV by acting on middle segment vessels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108811     DOI: 10.1007/BF03005577

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  20 in total

1.  The effects of halothane in hypoxic pulmonary vasoconstriction.

Authors:  D Johnson; I Mayers; T To
Journal:  Anesthesiology       Date:  1990-01       Impact factor: 7.892

Review 2.  Calculations and correction factors used in determination of blood pH and blood gases.

Authors:  R W Burnett; D C Noonan
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

3.  The effects of halothane on the pulmonary vascular bed of the dog.

Authors:  D C Heitz; P J Jebson; A R Boutros; M J Brody
Journal:  Anesthesiology       Date:  1971-07       Impact factor: 7.892

4.  Pulmonary vascular resistance. A meaningless variable.

Authors:  A Versprille
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

5.  Critical closure in the canine pulmonary vasculature.

Authors:  R Graham; C Skoog; L Oppenheimer; J Rabson; H S Goldberg
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

6.  Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes.

Authors:  A M Rudolph; S Yuan
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Role of prostaglandins in alveolar hypoxic vasoconstriction.

Authors:  C A Hales; E Rouse; I A Buchwald; H Kazemi
Journal:  Respir Physiol       Date:  1977-04

8.  The actions of halothane, ibuprofen and BW755C on hypoxic pulmonary vasoconstriction.

Authors:  C Marshall; S D Kim; B E Marshall
Journal:  Anesthesiology       Date:  1987-04       Impact factor: 7.892

9.  Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

Authors:  L J Rubin; J D Lazar
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Effects of arachidonate on permeability and resistance distribution in canine lungs.

Authors:  M I Townsley; R J Korthuis; A E Taylor
Journal:  J Appl Physiol (1985)       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.